Question · asked by 0 reviews
Enamel matrix derivative (EMD; Emdogain) vs Open flap debridement / control flap surgery (placebo vehicle gel in three trials): Marginal bone level change
- Population
- Patients affected by periodontitis, with intrabony defects to be treated
- Intervention
- Enamel matrix derivative (EMD; Emdogain)
- Comparison
- Open flap debridement / control flap surgery (placebo vehicle gel in three trials)
- Outcome
- Marginal bone level change
What each review found
Include earlier review versionsNo findings match. Try fewer words or remove a filter.
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Enamel matrix derivative (EMD; Emdogain) vs placebo or control · Patients affected by chronic, aggressive, or early onset periodontitis, with intrabony… · 1 review
- Enamel matrix derivative (EMD; Emdogain) vs Guided tissue regeneration (GTR) with barriers · Patients affected by chronic, aggressive, or early onset periodontitis, with intrabony… · 1 review
- Enamel matrix derivative (EMD; Emdogain) vs Various bone grafting (BG) procedures (animal-derived or synthetic bone / bioactive ceramic filler) · Patients affected by chronic, aggressive, or early onset periodontitis, with intrabony… · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.